ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceuticals Plant Protein Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-13D17549
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceuticals Plant Protein Market Research Report 2024
BUY CHAPTERS

Global Pharmaceuticals Plant Protein Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-13D17549
Report
October 2025
Pages:153
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ADM
Cargill Inc
DuPont
Kerry Group
Manildra
ROQUETTE
Tereos
Axiom Foods
Cosucra
CHS
Glanbia Nutritionals

Pharmaceuticals Plant Protein Market

The global Pharmaceuticals Plant Protein market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Pharmaceuticals plant proteins are derived from plants and utilized in the development and production of various medicinal and therapeutic products. These proteins are valued for their potential in creating biopharmaceuticals, including vaccines, antibodies, and enzymes, due to their ability to be produced in large quantities with relatively low cost and high safety profiles. They are engineered using plant-based systems such as tobacco, rice, and algae, which can be genetically modified to produce the desired protein.
From a downstream perspective, Dietary Supplements accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceuticals Plant Protein leading manufacturers including ADM, Cargill, DuPont, Kerry Group, Manildra, Roquette, Tereos, Axiom Foods, Cosucra, CHS, etc., dominate supply; the top five capture approximately % of global revenue, with ADM leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceuticals Plant Protein market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pharmaceuticals Plant Protein Market Report

Report Metric Details
Report Name Pharmaceuticals Plant Protein Market
Segment by Type
  • Soy Protein
  • Wheat Protein
  • Pea Protein
  • Others
Segment by Application
  • Dietary Supplements
  • Medicinal Protein
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ADM, Cargill, DuPont, Kerry Group, Manildra, Roquette, Tereos, Axiom Foods, Cosucra, CHS, Glanbia Nutritionals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pharmaceuticals Plant Protein study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pharmaceuticals Plant Protein Market report?

Ans: The main players in the Pharmaceuticals Plant Protein Market are ADM, Cargill, DuPont, Kerry Group, Manildra, Roquette, Tereos, Axiom Foods, Cosucra, CHS, Glanbia Nutritionals

What are the Application segmentation covered in the Pharmaceuticals Plant Protein Market report?

Ans: The Applications covered in the Pharmaceuticals Plant Protein Market report are Dietary Supplements, Medicinal Protein, Others

What are the Type segmentation covered in the Pharmaceuticals Plant Protein Market report?

Ans: The Types covered in the Pharmaceuticals Plant Protein Market report are Soy Protein, Wheat Protein, Pea Protein, Others

1 Study Coverage
1.1 Introduction to Pharmaceuticals Plant Protein: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceuticals Plant Protein Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Soy Protein
1.2.3 Wheat Protein
1.2.4 Pea Protein
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceuticals Plant Protein Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Dietary Supplements
1.3.3 Medicinal Protein
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceuticals Plant Protein Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceuticals Plant Protein Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Pharmaceuticals Plant Protein Sales Estimates and Forecasts 2020-2031
2.4 Global Pharmaceuticals Plant Protein Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Pharmaceuticals Plant Protein Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Pharmaceuticals Plant Protein Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Soy Protein Market Size by Manufacturers
3.5.2 Wheat Protein Market Size by Manufacturers
3.5.3 Pea Protein Market Size by Manufacturers
3.5.4 Others Market Size by Manufacturers
3.6 Global Pharmaceuticals Plant Protein Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceuticals Plant Protein Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceuticals Plant Protein Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceuticals Plant Protein Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Pharmaceuticals Plant Protein Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Pharmaceuticals Plant Protein Sales and Revenue by Type (2020-2031)
6.4 North America Pharmaceuticals Plant Protein Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceuticals Plant Protein Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Pharmaceuticals Plant Protein Sales and Revenue by Type (2020-2031)
7.4 Europe Pharmaceuticals Plant Protein Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceuticals Plant Protein Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Pharmaceuticals Plant Protein Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Pharmaceuticals Plant Protein Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Pharmaceuticals Plant Protein Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Pharmaceuticals Plant Protein Sales and Revenue by Type (2020-2031)
9.4 Central and South America Pharmaceuticals Plant Protein Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceuticals Plant Protein Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Pharmaceuticals Plant Protein Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Pharmaceuticals Plant Protein Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceuticals Plant Protein Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 ADM
11.1.1 ADM Corporation Information
11.1.2 ADM Business Overview
11.1.3 ADM Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.1.4 ADM Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 ADM Pharmaceuticals Plant Protein Sales by Product in 2024
11.1.6 ADM Pharmaceuticals Plant Protein Sales by Application in 2024
11.1.7 ADM Pharmaceuticals Plant Protein Sales by Geographic Area in 2024
11.1.8 ADM Pharmaceuticals Plant Protein SWOT Analysis
11.1.9 ADM Recent Developments
11.2 Cargill
11.2.1 Cargill Corporation Information
11.2.2 Cargill Business Overview
11.2.3 Cargill Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.2.4 Cargill Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Cargill Pharmaceuticals Plant Protein Sales by Product in 2024
11.2.6 Cargill Pharmaceuticals Plant Protein Sales by Application in 2024
11.2.7 Cargill Pharmaceuticals Plant Protein Sales by Geographic Area in 2024
11.2.8 Cargill Pharmaceuticals Plant Protein SWOT Analysis
11.2.9 Cargill Recent Developments
11.3 DuPont
11.3.1 DuPont Corporation Information
11.3.2 DuPont Business Overview
11.3.3 DuPont Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.3.4 DuPont Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 DuPont Pharmaceuticals Plant Protein Sales by Product in 2024
11.3.6 DuPont Pharmaceuticals Plant Protein Sales by Application in 2024
11.3.7 DuPont Pharmaceuticals Plant Protein Sales by Geographic Area in 2024
11.3.8 DuPont Pharmaceuticals Plant Protein SWOT Analysis
11.3.9 DuPont Recent Developments
11.4 Kerry Group
11.4.1 Kerry Group Corporation Information
11.4.2 Kerry Group Business Overview
11.4.3 Kerry Group Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.4.4 Kerry Group Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Kerry Group Pharmaceuticals Plant Protein Sales by Product in 2024
11.4.6 Kerry Group Pharmaceuticals Plant Protein Sales by Application in 2024
11.4.7 Kerry Group Pharmaceuticals Plant Protein Sales by Geographic Area in 2024
11.4.8 Kerry Group Pharmaceuticals Plant Protein SWOT Analysis
11.4.9 Kerry Group Recent Developments
11.5 Manildra
11.5.1 Manildra Corporation Information
11.5.2 Manildra Business Overview
11.5.3 Manildra Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.5.4 Manildra Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Manildra Pharmaceuticals Plant Protein Sales by Product in 2024
11.5.6 Manildra Pharmaceuticals Plant Protein Sales by Application in 2024
11.5.7 Manildra Pharmaceuticals Plant Protein Sales by Geographic Area in 2024
11.5.8 Manildra Pharmaceuticals Plant Protein SWOT Analysis
11.5.9 Manildra Recent Developments
11.6 Roquette
11.6.1 Roquette Corporation Information
11.6.2 Roquette Business Overview
11.6.3 Roquette Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.6.4 Roquette Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Roquette Recent Developments
11.7 Tereos
11.7.1 Tereos Corporation Information
11.7.2 Tereos Business Overview
11.7.3 Tereos Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.7.4 Tereos Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Tereos Recent Developments
11.8 Axiom Foods
11.8.1 Axiom Foods Corporation Information
11.8.2 Axiom Foods Business Overview
11.8.3 Axiom Foods Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.8.4 Axiom Foods Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Axiom Foods Recent Developments
11.9 Cosucra
11.9.1 Cosucra Corporation Information
11.9.2 Cosucra Business Overview
11.9.3 Cosucra Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.9.4 Cosucra Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Cosucra Recent Developments
11.10 CHS
11.10.1 CHS Corporation Information
11.10.2 CHS Business Overview
11.10.3 CHS Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.10.4 CHS Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 CHS Recent Developments
11.11 Glanbia Nutritionals
11.11.1 Glanbia Nutritionals Corporation Information
11.11.2 Glanbia Nutritionals Business Overview
11.11.3 Glanbia Nutritionals Pharmaceuticals Plant Protein Product Models, Descriptions and Specifications
11.11.4 Glanbia Nutritionals Pharmaceuticals Plant Protein Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Glanbia Nutritionals Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Pharmaceuticals Plant Protein Industry Chain
12.2 Pharmaceuticals Plant Protein Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Pharmaceuticals Plant Protein Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Pharmaceuticals Plant Protein Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceuticals Plant Protein Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceuticals Plant Protein Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
ADM
Cargill Inc
DuPont
Kerry Group
Manildra
ROQUETTE
Tereos
Axiom Foods
Cosucra
CHS
Glanbia Nutritionals
List of Tables
 Table 1. Global Pharmaceuticals Plant Protein Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pharmaceuticals Plant Protein Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pharmaceuticals Plant Protein Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pharmaceuticals Plant Protein Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pharmaceuticals Plant Protein Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Pharmaceuticals Plant Protein Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Kilotons)
 Table 7. Global Pharmaceuticals Plant Protein Sales by Region (2020-2025) & (Kilotons)
 Table 8. Global Pharmaceuticals Plant Protein Sales by Region (2026-2031) & (Kilotons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Pharmaceuticals Plant Protein Sales by Manufacturers (2020-2025) & (Kilotons)
 Table 11. Global Pharmaceuticals Plant Protein Sales Share by Manufacturers (2020-2025)
 Table 12. Global Pharmaceuticals Plant Protein Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Pharmaceuticals Plant Protein Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Pharmaceuticals Plant Protein by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceuticals Plant Protein as of 2024)
 Table 16. Global Pharmaceuticals Plant Protein Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Pharmaceuticals Plant Protein Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
 Table 18. Key Manufacturers Pharmaceuticals Plant Protein Manufacturing Base and Headquarters
 Table 19. Global Pharmaceuticals Plant Protein Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Pharmaceuticals Plant Protein Sales by Type (2020-2025) & (Kilotons)
 Table 23. Global Pharmaceuticals Plant Protein Sales by Type (2026-2031) & (Kilotons)
 Table 24. Global Pharmaceuticals Plant Protein Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Pharmaceuticals Plant Protein Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmaceuticals Plant Protein ASP by Type (2020-2031) & (US$/Ton)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Pharmaceuticals Plant Protein Sales by Application (2020-2025) & (Kilotons)
 Table 29. Global Pharmaceuticals Plant Protein Sales by Application (2026-2031) & (Kilotons)
 Table 30. Pharmaceuticals Plant Protein High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Pharmaceuticals Plant Protein Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Pharmaceuticals Plant Protein Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Pharmaceuticals Plant Protein ASP by Application (2020-2031) & (US$/Ton)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Pharmaceuticals Plant Protein Growth Accelerators and Market Barriers
 Table 37. North America Pharmaceuticals Plant Protein Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Pharmaceuticals Plant Protein Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Pharmaceuticals Plant Protein Growth Accelerators and Market Barriers
 Table 40. Europe Pharmaceuticals Plant Protein Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Pharmaceuticals Plant Protein Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Pharmaceuticals Plant Protein Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Pharmaceuticals Plant Protein Sales (Kilotons) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Pharmaceuticals Plant Protein Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Pharmaceuticals Plant Protein Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Pharmaceuticals Plant Protein Investment Opportunities and Key Challenges
 Table 47. Central and South America Pharmaceuticals Plant Protein Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Pharmaceuticals Plant Protein Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Pharmaceuticals Plant Protein Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. ADM Corporation Information
 Table 51. ADM Description and Major Businesses
 Table 52. ADM Product Models, Descriptions and Specifications
 Table 53. ADM Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 54. ADM Sales Value Proportion by Product in 2024
 Table 55. ADM Sales Value Proportion by Application in 2024
 Table 56. ADM Sales Value Proportion by Geographic Area in 2024
 Table 57. ADM Pharmaceuticals Plant Protein SWOT Analysis
 Table 58. ADM Recent Developments
 Table 59. Cargill Corporation Information
 Table 60. Cargill Description and Major Businesses
 Table 61. Cargill Product Models, Descriptions and Specifications
 Table 62. Cargill Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 63. Cargill Sales Value Proportion by Product in 2024
 Table 64. Cargill Sales Value Proportion by Application in 2024
 Table 65. Cargill Sales Value Proportion by Geographic Area in 2024
 Table 66. Cargill Pharmaceuticals Plant Protein SWOT Analysis
 Table 67. Cargill Recent Developments
 Table 68. DuPont Corporation Information
 Table 69. DuPont Description and Major Businesses
 Table 70. DuPont Product Models, Descriptions and Specifications
 Table 71. DuPont Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 72. DuPont Sales Value Proportion by Product in 2024
 Table 73. DuPont Sales Value Proportion by Application in 2024
 Table 74. DuPont Sales Value Proportion by Geographic Area in 2024
 Table 75. DuPont Pharmaceuticals Plant Protein SWOT Analysis
 Table 76. DuPont Recent Developments
 Table 77. Kerry Group Corporation Information
 Table 78. Kerry Group Description and Major Businesses
 Table 79. Kerry Group Product Models, Descriptions and Specifications
 Table 80. Kerry Group Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 81. Kerry Group Sales Value Proportion by Product in 2024
 Table 82. Kerry Group Sales Value Proportion by Application in 2024
 Table 83. Kerry Group Sales Value Proportion by Geographic Area in 2024
 Table 84. Kerry Group Pharmaceuticals Plant Protein SWOT Analysis
 Table 85. Kerry Group Recent Developments
 Table 86. Manildra Corporation Information
 Table 87. Manildra Description and Major Businesses
 Table 88. Manildra Product Models, Descriptions and Specifications
 Table 89. Manildra Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 90. Manildra Sales Value Proportion by Product in 2024
 Table 91. Manildra Sales Value Proportion by Application in 2024
 Table 92. Manildra Sales Value Proportion by Geographic Area in 2024
 Table 93. Manildra Pharmaceuticals Plant Protein SWOT Analysis
 Table 94. Manildra Recent Developments
 Table 95. Roquette Corporation Information
 Table 96. Roquette Description and Major Businesses
 Table 97. Roquette Product Models, Descriptions and Specifications
 Table 98. Roquette Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 99. Roquette Recent Developments
 Table 100. Tereos Corporation Information
 Table 101. Tereos Description and Major Businesses
 Table 102. Tereos Product Models, Descriptions and Specifications
 Table 103. Tereos Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 104. Tereos Recent Developments
 Table 105. Axiom Foods Corporation Information
 Table 106. Axiom Foods Description and Major Businesses
 Table 107. Axiom Foods Product Models, Descriptions and Specifications
 Table 108. Axiom Foods Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 109. Axiom Foods Recent Developments
 Table 110. Cosucra Corporation Information
 Table 111. Cosucra Description and Major Businesses
 Table 112. Cosucra Product Models, Descriptions and Specifications
 Table 113. Cosucra Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 114. Cosucra Recent Developments
 Table 115. CHS Corporation Information
 Table 116. CHS Description and Major Businesses
 Table 117. CHS Product Models, Descriptions and Specifications
 Table 118. CHS Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 119. CHS Recent Developments
 Table 120. Glanbia Nutritionals Corporation Information
 Table 121. Glanbia Nutritionals Description and Major Businesses
 Table 122. Glanbia Nutritionals Product Models, Descriptions and Specifications
 Table 123. Glanbia Nutritionals Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 124. Glanbia Nutritionals Recent Developments
 Table 125. Key Raw Materials Distribution
 Table 126. Raw Materials Key Suppliers
 Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 128. Milestones in Production Technology Evolution
 Table 129. Distributors List
 Table 130. Market Trends and Market Evolution
 Table 131. Market Drivers and Opportunities
 Table 132. Market Challenges, Risks, and Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmaceuticals Plant Protein Product Picture
 Figure 2. Global Pharmaceuticals Plant Protein Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Soy Protein Product Picture
 Figure 4. Wheat Protein Product Picture
 Figure 5. Pea Protein Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Pharmaceuticals Plant Protein Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Dietary Supplements
 Figure 9. Medicinal Protein
 Figure 10. Others
 Figure 11. Pharmaceuticals Plant Protein Report Years Considered
 Figure 12. Global Pharmaceuticals Plant Protein Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Pharmaceuticals Plant Protein Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Pharmaceuticals Plant Protein Revenue Market Share by Region (2020-2031)
 Figure 16. Global Pharmaceuticals Plant Protein Sales (2020-2031) & (Kilotons)
 Figure 17. Global Pharmaceuticals Plant Protein Sales (CAGR) by Region (2020-2031) (Kilotons)
 Figure 18. Global Pharmaceuticals Plant Protein Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers Pharmaceuticals Plant Protein Sales Volume Market Share in 2024
 Figure 20. Global Pharmaceuticals Plant Protein Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Soy Protein Revenue Market Share by Manufacturer in 2024
 Figure 23. Wheat Protein Revenue Market Share by Manufacturer in 2024
 Figure 24. Pea Protein Revenue Market Share by Manufacturer in 2024
 Figure 25. Others Revenue Market Share by Manufacturer in 2024
 Figure 26. Global Pharmaceuticals Plant Protein Sales Market Share by Type (2020-2031)
 Figure 27. Global Pharmaceuticals Plant Protein Revenue Market Share by Type (2020-2031)
 Figure 28. Global Pharmaceuticals Plant Protein Sales Market Share by Application (2020-2031)
 Figure 29. Global Pharmaceuticals Plant Protein Revenue Market Share by Application (2020-2031)
 Figure 30. North America Pharmaceuticals Plant Protein Sales YoY (2020-2031) & (Kilotons)
 Figure 31. North America Pharmaceuticals Plant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers Pharmaceuticals Plant Protein Sales Revenue (US$ Million) in 2024
 Figure 33. North America Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 34. North America Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 35. North America Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Application (2020-2031)
 Figure 36. North America Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe Pharmaceuticals Plant Protein Sales YoY (2020-2031) & (Kilotons)
 Figure 41. Europe Pharmaceuticals Plant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers Pharmaceuticals Plant Protein Sales Revenue (US$ Million) in 2024
 Figure 43. Europe Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Type (2020-2031)
 Figure 44. Europe Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Europe Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Application (2020-2031)
 Figure 46. Europe Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 48. France Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Pharmaceuticals Plant Protein Sales YoY (2020-2031) & (Kilotons)
 Figure 53. Asia-Pacific Pharmaceuticals Plant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers Pharmaceuticals Plant Protein Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Type (2020- 2031)
 Figure 56. Asia-Pacific Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 57. Asia-Pacific Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Application (2020-2031)
 Figure 58. Asia-Pacific Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 63. India Pharmaceuticals Plant Protein Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America Pharmaceuticals Plant Protein Sales YoY (2020-2031) & (Kilotons)
 Figure 65. Central and South America Pharmaceuticals Plant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers Pharmaceuticals Plant Protein Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Type (2021-2031)
 Figure 68. Central and South America Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 69. Central and South America Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Application (2020-2031)
 Figure 70. Central and South America Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil Pharmaceuticals Plant Protein Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina Pharmaceuticals Plant Protein Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa Pharmaceuticals Plant Protein Sales YoY (2020-2031) & (Kilotons)
 Figure 74. Middle East and Africa Pharmaceuticals Plant Protein Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers Pharmaceuticals Plant Protein Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Type (2021-2031)
 Figure 77. South America Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Middle East and Africa Pharmaceuticals Plant Protein Sales Volume (Kilotons) by Application (2020-2031)
 Figure 79. Middle East and Africa Pharmaceuticals Plant Protein Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries Pharmaceuticals Plant Protein Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey Pharmaceuticals Plant Protein Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt Pharmaceuticals Plant Protein Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa Pharmaceuticals Plant Protein Revenue (2020-2025) & (US$ Million)
 Figure 84. Pharmaceuticals Plant Protein Industry Chain Mapping
 Figure 85. Regional Pharmaceuticals Plant Protein Manufacturing Base Distribution (%)
 Figure 86. Global Pharmaceuticals Plant Protein Production Market Share by Region (2020-2031)
 Figure 87. Pharmaceuticals Plant Protein Production Process
 Figure 88. Regional Pharmaceuticals Plant Protein Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Plant Derived Protein Market Research Report 2024
Global Plant based Protein Production Service Market Research Report 2025
Global Food Plant Protein Market Research Report 2024
Global Plant based Protein Products Market Research Report 2024
Global Plant Protein based Food Market Insights Forecast to 2030
Global Plant Derived Proteins Market Research Report 2024
Global Hydrolyzed Plant Protein Market Insights Forecast to 2030
Soybean Plant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Feed Plant Protein Market Research Report 2024
Global Plant Sourced Protein Market Research Report 2024
Global Plant based Alternative Protein Market Research Report 2024
Global Plant Derived Protein Hydrolysate Market Research Report 2025
Global Mung Bean Protein Market Research Report 2024
Plant Based Dietary Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fermented Plant Protein Market Research Report 2025
Global Tobacco Plant Vaccines Market Research Report 2024
Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Insights Forecast to 2030
Global Plant Protein Nutrition Market Research Report 2025
Feed Plant based Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Soy Plant Protein Market Research Report 2024

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions